Hostname: page-component-586b7cd67f-t7czq Total loading time: 0 Render date: 2024-11-24T18:23:09.016Z Has data issue: false hasContentIssue false
  • English
  • Français

Show Me the Money: Long-Term Financial Impact of an Antimicrobial Stewardship Program

Published online by Cambridge University Press:  02 January 2015

James R. Beardsley ,
John C. Williamson ,
James W. Johnson ,
Vera P. Luther ,
Rebekah H. Wrenn  and
Christopher C. Ohl
James R. Beardsley*
Affiliation:
Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
John C. Williamson
Affiliation:
Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
James W. Johnson
Affiliation:
Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
Vera P. Luther
Affiliation:
Section on Infectious Diseases, Wake Forest School of Medicine, Winston-Salem, North Carolina
Rebekah H. Wrenn
Affiliation:
Department of Pharmacy, Wake Forest Baptist Medical Center, Winston-Salem, North Carolina
Christopher C. Ohl
Affiliation:
Section on Infectious Diseases, Wake Forest School of Medicine, Winston-Salem, North Carolina
*
Department of Pharmacy, Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27410 ([email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

The financial impact of an antimicrobial stewardship program in operation for more than 11 years was determined by calculating the reduction in antimicrobial expenditures minus program labor costs. Depending on the method of inflation adjustment used, the program was associated with average cost savings of $920,070 to $2,064,441 per year.

Type
Concise Communication
Information
Infection Control & Hospital Epidemiology , Volume 33 , Issue 4: Special Topic Issue: Antimicrobial Stewardship , April 2012 , pp. 398 - 400
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Dellit, TH, Owens, RC, McGowan, JE, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.CrossRefGoogle Scholar
2. Ohl, CA, Luther, VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med 2011;6(suppl 1):S4–S15.CrossRefGoogle ScholarPubMed
3. US Department of Labor, Bureau of Labor Statistics. Archived Consumer Price Index Detailed Report Information. http://www.bls.gov/cpi/cpi_dr.htm#2000. Accessed November 21, 2011.Google Scholar
4. Shah, ND, Vermeulen, LC, Santell, P, Hunkler, RJ, Hontz, K. Projecting drug expenditures—2002. Am J Health Syst Pharm 2002; 59:131–142.CrossRefGoogle ScholarPubMed
5. Doloresco, F, Fominaya, C, Schumock, GT, et al. Projecting future drug expenditures—2011. Am J Health Syst Pharm 2011;68:921–932.CrossRefGoogle Scholar
6. Fishman, N. Antimicrobial stewardship. Am J Med 2006;119(6 suppl 1):S53–S61.CrossRefGoogle ScholarPubMed
7. Hanzelka, KM, Pierce, CA, Beardsley, JR, Williamson, JC, Morris, PE. Influence of an institution-specific sepsis protocol on the adequacy of empiric antimicrobial therapy. Hosp Pharm 2010;45:538–544.CrossRefGoogle Scholar
8. Wrenn, RH, Beardsley, J, Williamson, J, et al. Hospital acquired pneumonia guidelines based on local microbiologic data improve adequacy of empiric therapy. In: Abstracts of the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago: September 17-20, 2011. Abstract K-1449.Google Scholar